| Ascendis Pharma ADR (ASND) | |||
|---|---|---|---|
| 98.93 4.02 (4.24%) | 08-08 16:00 | ||
| Open: | 95.28 | Pre. Close: | 94.91 |
| High: | 99.99 | Low: | 94.96 |
| Volume: | 1,369,387 | Market Cap: | 5,636M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 100.05 - 100.346 | 100.346 - 100.677 |
| Low: | 94.084 - 94.436 | 94.436 - 94.83 |
| Close: | 98.29 - 98.838 | 98.838 - 99.451 |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 116.79  One year: 136.41 |
| Support: | Support1: 89.30 Support2: 82.70 |
| Resistance: | Resistance1: 99.99 Resistance2: 116.79 |
| Pivot: | 89.15 |
| Moving Averages: | MA(5): 92.25 MA(20): 88.62 MA(100): 94.85  MA(250): 120.52 |
| MACD: | MACD(12,26): 0.99 Signal(12,26,9): -0.12 |
| %K %D: | %K(14,3): 92.72 %D(3): 82.18 |
| RSI: | RSI(14): 66.93 |
| 52-Week: | High: 178.71 Low: 61.579 Change(%): -14.9 |
| Average Vol(K): | 3-Month: 389 10-Days: 475 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ASND ] has closed Bollinger Bands are 21.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
Mon, 19 Oct 2020 European ADRs Move Higher in Monday Trading - InvestorsObserver Wed, 31 Dec 1969 Wed, 31 Dec 1969 Wed, 31 Dec 1969 Wed, 31 Dec 1969 Wed, 31 Dec 1969 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Global Select | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | |
| Shares Float (M) | 56.97 |
| % Held by Insiders | 43190000.00 |
| % Held by Institutions | 0.07 |
| Shares Short (K) | 5930 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | -450489984.000 |
| Book Value (p.s.) | |
| Profit Margin | |
| Operating Margin | -3.00 |
| Return on Assets (ttm) | 284.1 |
| Return on Equity (ttm) | -24.3 |
| Qtrly Rev. Growth | 13860000.0 |
| Gross Profit (p.s.) | 1216.866 |
| Sales Per Share | -90.284 |
| EBITDA (p.s.) | 6343283.500 |
| Qtrly Earnings Growth | -8.46 |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | -466.82 |
| Stock Valuation | |
|---|---|
| PE Ratio | |
| PEG Ratio | 8.32 |
| Price to Book value | |
| Price to Sales | -1.10 |
| Price to Cash Flow | 5.50 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | 6870000.000 |
